Streetbeat News

AUVI

Applied UV Inc

https://www.applieduvinc.com/

applied uv, inc. engages in the design, manufacture, assembly, and distribution of automated disinfecting mirror systems for use in hospitals and other healthcare facilities. the company also manufactures and supplies custom designed decorative framed mirrors, framed arts, and bathroom vanities primarily to the hospitality market. it has operations in the united states and internationally. applied uv, inc. was founded in 2012 and is headquartered in mount vernon, new york.

Open

0.29

Mkt cap

1.4M

Volume

5.6M

High

0.29

P/E Ratio

-0.01

52-wk high

57.00

Low

0.29

Div yield

N/A

52-wk low

0.18

Applied UV (NASDAQ:AUVI) reported a narrower Q3 loss of $(0.32) per share compared to $(1.20) per share in the same quarter last year. Sales for the quarter increased by 94.79% to $11.45 million from $5.88 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 19, 2023 | 8:30 pm

U.S. stocks saw significant gains with the Dow Jones rising over 500 points. Home Depot (HD) reported third-quarter results that exceeded expectations, with a 3% year-on-year sales decline to $37.71 billion, surpassing analyst estimates of $35.66 billion, and an EPS of $3.81 beating the consensus of $3.58. Real estate shares led the market with a 5% surge, while energy shares had a modest increase of 0.5%. BioCardia (BCDA), INVO Bioscience (INVO), and Theseus Pharmaceuticals (THRX) experienced substantial stock price increases due to positive company developments. Conversely, The Beauty Health Company (SKIN), Kubient (KBNT), and Applied UV (AUVI) saw their shares plummet following negative financial results and company announcements.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 8:10 pm

Beyond Air, Inc. (XAIR) shares dropped by 37.3% to $1.2701 due to weaker than expected quarterly results, with a loss of 51 cents per share and sales of $239,000 against expectations of $480,000. Other stocks experienced significant movements in Tuesday's mid-day session, with notable gainers including BioCardia, Inc. (BCDA), reAlpha Tech Corp. (AIRE), and Theseus Pharmaceuticals, Inc. (THRX), among others. Losers included Li-Cycle Holdings Corp. (LICY) and The Beauty Health Company (SKIN), which both saw sharp declines after reporting disappointing financial results.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 7:05 pm

U.S. stocks traded higher with the Dow Jones gaining around 500 points. Real estate shares surged by 4.6%, while energy shares rose by 0.2%. The U.S. annual inflation rate decreased to 3.2% in October. BioCardia, Inc. (BCDA) soared 206% after FDA approval for a Phase 3 clinical trial. INVO Bioscience, Inc. (INVO) rose 28% after posting a narrower Q3 loss. Theseus Pharmaceuticals, Inc. (THRX) gained 50% after announcing a strategic alternatives exploration process. The Beauty Health Company (SKIN) plunged 60% due to weak Q3 results and a suspended 2025 forecast. Kubient, Inc. (KBNT) dropped 51% after announcing a voluntary delisting from Nasdaq. Applied UV, Inc. (AUVI) fell 44% after pricing a public offering. Oil and gold prices increased.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 6:11 pm

Applied UV shares are trading lower following the announcement of a $6.4 million upsized underwritten public offering.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 5:20 pm

Applied UV Inc (NASDAQ:AUVI) stock plummeted by 43% to $0.15 after the company announced the pricing of its public offering at $0.15 per unit, aiming to raise $6.4 million in gross proceeds. The offering was increased from $6.0 million and includes options for Aegis Capital Corp. to buy additional shares and warrants. The funds are intended for repaying notes and general corporate purposes, with the offering expected to close on November 16.

Portfolio Pulse from Henry Khederian

November 14, 2023 | 5:18 pm

U.S. stocks traded higher with the Dow Jones gaining around 400 points. The NASDAQ surged 2.03% and the S&P 500 rose 1.61%. U.S. annual inflation rate slowed to 3.2% in October, below market estimates. BioCardia, Inc. soared 243% after FDA approval for a clinical trial. INVO Bioscience and Theseus Pharmaceuticals also saw significant gains. The Beauty Health Company, Kubient, Inc., and Applied UV faced sharp declines after negative reports. Oil and gold prices increased, while European and Asian markets showed mixed results.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 2:50 pm

Applied UV, Inc. has announced the pricing of an upsized underwritten public offering, aiming to raise $6.4 million through the sale of 42,666,666 units at $0.15 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 2:37 pm

In Tuesday's pre-market session, several industrial stocks showed significant movement. Gainers included BioNexus Gene Lab (BGLC), Jet AI (JTAI), Beam Glb (BEEM), Broadwind (BWEN), Sunworks (SUNW), and Microvast Holdings (MVST), with increases ranging from 6.34% to 15.1%, largely attributed to recent Q3 earnings releases. Losers were Applied UV (AUVI), Bridger Aerospace Gr (BAER), Li-Cycle Holdings (LICY), iSun (ISUN), Asure Software (ASUR), and NET Power (NPWR), with declines between 5.26% and 33.3%, also following their Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

INVO Bioscience, Inc. (NASDAQ:INVO) shares increased by over 31% in pre-market trading due to a narrower Q3 loss and a 314% surge in quarterly sales. Other stocks experienced pre-market movements, with notable gainers including TCRT, AIRE, HRYU, THRX, RDHL, ABSI, PXMD, ADN, OMIC, and losers such as SKIN, HROW, AUVI, AKLI, HTCR, PRSO, FSR, TCON, TENX, XAIR.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.